Dr. Van Morris is an assistant professor in the Department of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston, TX. He completed his fellowship in hematology/oncology at MD Anderson, where he stayed for an additional year as an Advanced Scholar performing translational research on BRAF-mutated metastatic colorectal cancer before joining the faculty. His clinical practice focuses on the treatment of colorectal and anal cancers, and he has written multiple clinical trials which incorporate novel therapeutic approaches involving targeted therapies and immunotherapy. His work has been featured in publications in the New England Journal of Medicine, Lancet Oncology, Cancer Discovery, JAMA Oncology, and the Journal of Clinical Oncology. His work has been supported as a recipient of the ASCO Young investigator Award, NIH/NCI K12 Award, Khalifa Scholar Award, SWOG Hope Foundation Award, and NIH/NCI Colorectal Cancer SPORE Early Career Award.